Song Zheming, Du Boxiang, Wang Kai, Shi Xueyin
1 Department of Anesthesiology, Changzheng Hospital, Second Military Medical University , Shanghai, China .
Genet Test Mol Biomarkers. 2013 Oct;17(10):743-9. doi: 10.1089/gtmb.2013.0282. Epub 2013 Aug 2.
Emerging evidence has shown that the most common polymorphism (A118G; rs1799971 A>G) in the μ-opioid receptor (OPRM1) gene may influence the response to labor analgesia, but individually published studies showed inconclusive results.
This meta-analysis aimed to derive a more precise estimation of the effects of the OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor.
A literature search was conducted on PubMed, Embase, Web of Science, and China BioMedicine databases before April 1st, 2013. The crude standardized mean difference (SMD) or odds ratio (OR) with 95% confidence interval (CI) was calculated.
Six clinical studies were included with a total 838 women who received epidural analgesia with fentanyl during labor. The meta-analysis results indicated that women carrying the G allele (AG+GG) of the OPRM1 A118G polymorphism required less fentanyl doses to achieve adequate pain relief compared with those with the AA homozygote (SMD=-0.24, 95% CI [-0.44, -0.03], p=0.022). The 118G variant was associated with a decreased ED50 of fentanyl for labor analgesia (SMD=-1.56, 95% CI [-1.97, -1.15], p<0.001). The analgesia satisfaction in women carrying the G allele (AG+GG) was higher than those with the AA homozygote (SMD=0.22, 95% CI [0.05, 0.39], p=0.012). However, there were no statistically significant differences between an AA homozygote and a G carrier (AG+GG) in the incidence of nausea and vomiting (OR=1.99, 95% CI [0.88, 4.52], p=0.101).
In conclusion, the current meta-analysis indicates that women carrying the G allele (AG+GG) of OPRM1 A118G polymorphism may have a good response to epidural analgesia with fentanyl during labor. The OPRM1 A118G polymorphism may help predict individuals' response to epidural labor analgesia and so optimize postoperative pain control.
新出现的证据表明,μ-阿片受体(OPRM1)基因中最常见的多态性(A118G;rs1799971 A>G)可能会影响分娩镇痛的效果,但个别发表的研究结果并不确定。
本荟萃分析旨在更精确地评估OPRM1 A118G多态性对分娩期间芬太尼硬膜外镇痛效果的影响。
于2013年4月1日前在PubMed、Embase、Web of Science和中国生物医学数据库进行文献检索。计算粗标准化均数差(SMD)或比值比(OR)及95%置信区间(CI)。
纳入6项临床研究,共838名在分娩期间接受芬太尼硬膜外镇痛的女性。荟萃分析结果表明,与AA纯合子女性相比,携带OPRM1 A118G多态性G等位基因(AG+GG)的女性达到充分疼痛缓解所需的芬太尼剂量更少(SMD=-0.24,95%CI[-0.44,-0.03],p=0.022)。118G变异与分娩镇痛芬太尼的半数有效剂量(ED50)降低相关(SMD=-1.56,95%CI[-1.97,-1.15],p<0.001)。携带G等位基因(AG+GG)的女性的镇痛满意度高于AA纯合子女性(SMD=0.22,95%CI[0.05,0.39],p=0.012)。然而,AA纯合子和G等位基因携带者(AG+GG)在恶心和呕吐发生率方面无统计学显著差异(OR=1.99,95%CI[0.88,4.52],p=0.101)。
总之,当前的荟萃分析表明,携带OPRM1 A118G多态性G等位基因(AG+GG)的女性在分娩期间可能对芬太尼硬膜外镇痛反应良好。OPRM1 A118G多态性可能有助于预测个体对硬膜外分娩镇痛的反应,从而优化术后疼痛控制。